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Abstract
Dengue disease, which is caused by dengue virus infection, is a major public health in the 
tropical and subtropical countries in the world. It has a wide spectrum of clinical mani-
festations ranging from an undifferentiated fever in a mild clinical form (dengue fever 
[DF]) to the severe clinical and potentially fatal dengue hemorrhagic fever and shock 
syndrome (DHF/DSS). Recently, a study has suggested that excessive inflammation and 
apoptosis contribute to the pathogenesis of severe dengue disease. Soluble FasL is a type 
II membrane protein belonging to the tumor necrosis factor (TNF) family, which induces 
apoptosis in Fas-bearing cells and neutrophil chemotactic functions. The apoptosis of 
microvascular endothelial cells may explain the plasma leakage mechanism in DHF and 
there was a significant increase in soluble Fas-ligand level in DHF patients compared to 
DF patients. It can be concluded that the soluble Fas ligand is related to the pathogenesis 
of dengue infection.
Keywords: soluble Fas ligand, dengue fever, dengue hemorrhagic fever, apoptosis, 
immune response
1. Introduction
Dengue is a public health problem in much of the tropical and subtropical countries in the 
world. Two-thirds of the world’s population is at risk of dengue infection; an estimated 50 
million cases occur annually, and around 2.5% of those affected die [1]. Dengue has a wide 
spectrum of clinical presentations and often has unpredictable clinical outcomes, may be 
asymptomatic, or may cause undifferentiated febrile illness (viral syndrome), dengue fever 
(DF), or dengue hemorrhagic fever (DHF) including dengue shock syndrome (DSS), and this 
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can cause death [2]. Despite much research, pathogenesis which can explain the severity of 
dengue remains unclear [3, 4]. Severe dengue is characterized by plasma leakage and abnor-
mal bleeding that can lead to shock and death [1, 2, 5]. Pathogenesis of severe dengue diseases 
(DHF/DSS) has been suggested to be caused by the amplified production of cytokines that ulti-
mately targets the vascular endothelium and leads to an increase in vascular permeability [4, 
6, 7]. There is currently no specific treatment for severe dengue due to gaps in understanding 
the underlying mechanisms.
Soluble FasL is a type II membrane protein belonging to the tumor necrosis factor (TNF) fam-
ily, which induces apoptosis in Fas-bearing cells [8] and neutrophil chemotactic functions [9]. 
A recent study showed that in addition to the immune response, apoptosis also contributes to 
the pathogenesis of DHF. An autopsy examination showed that dengue cases show apoptosis 
in liver cells, brain, intestine, and lungs. The apoptosis of microvascular endothelial cells may 
explain the plasma leakage mechanism in DHF [10].
2. Role of soluble Fas ligand in the severity of dengue disease
2.1. Dengue infection
Dengue fever (DF) and its severe forms, dengue hemorrhagic fever (DHF) and dengue shock 
syndrome (DSS), have become a major international public health problem, especially in the 
tropical and subtropical regions around the world. An estimated 50 million infections per 
year occur across approximately 100 countries, with potential for further spread [1, 2]. The 
disease is caused by a virus belonging to the family Flaviviridae that is spread by Aedes 
mosquitoes. There are four distinct serotypes of dengue virus (DENV 1–4). All dengue sero-
types are capable of causing diseases with a wide spectrum of clinical manifestations, ranging 
from an undifferentiated fever in a mild clinical form (DF) to the severe clinical and poten-
tially fatal DHF/DSS. Infection with one serotype confers protective immunity against that 
serotype but not against other serotypes [11]. Dengue fever (DF) is an acute and self-limited 
illness manifested by fever, headache, myalgia, and arthralgia, and on physical examina-
tion there occurs rash. Laboratory tests reveal leukopenia and thrombocytopenia. The more 
severe dengue DHF is complicated by plasma leakage that occurs around 3–5 days after the 
disease. A sudden and extensive plasma leakage may result in shock or death, a phenomenon 
called DSS. Then, patients undergo a defervescence phase marked by an abrupt drop in body 
temperature, at which point the illness may either wane to recovery or proceed to serious 
complications [1, 5].
DENV infection in humans starts with a DENV-infected mosquito bite. DENV can replicate in 
a wide spectrum of cells, including liver, spleen, lymph node, kidney, and other organs, but 
monocytes, macrophages, and dendritic cells (DC) have been shown to be the major targets 
for DENV [12]. Monocytes and T lymphocytes, which are infected by DENV, produce several 
pro-inflammatory mediators which become sources of intense cytokine production [13].
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Abnormal hemostasis and plasma leakage are the main pathophysiological hallmarks in 
DHF. There is no vasculitis and hence no injury to the vessel walls, and plasma leakage results 
from the cytokine-mediated increase in vascular permeability [14]. During inflammation, 
increased vascular permeability occurs primarily via changes in the integrity of inter-endo-
thelial cell junctions. The increase vascular permeability is affected by a number of soluble 
factors on the endothelium and among them are thrombin, bradykinin, histamine, oxygen 
free radicals, vascular endothelial growth factor (VEGF), and tumor necrosis factor-α (TNFα) 
[15]. Some neutrophil products like arachidonic acid (AA) or leukotriene (LT) A4 are fur-
ther processed by endothelial enzymes through transcellular metabolism before the resulting 
products thromboxane A2, LTB4, or LTC4 can activate their cognate receptors. Neutrophils 
also generate reactive oxygen species that induce vascular leakage [16].
2.2. Fas ligand
Fas ligand is a 40-kDa type II membrane protein belonging to the tumor necrosis factor (TNF) 
family of proteins which induce defined cellular responses upon binding to their respective 
receptors (Fas receptors). The interaction of Fas ligand with its receptor induced programmed 
cell death (apoptosis) [8].
FasL is expressed by many cell types; it is primarily recognized as associated with activated T 
lymphocytes and natural killer (NK) cells [17]. Fas ligand is expressed in three distinct forms:
1. a membranous form on the cell surface;
2. a membranous form stored in intracellular microvesicles which are excreted into the inter-
cellular milieu in response to various physiologic stimuli; and
3. the soluble form generated from the cleavage of the membranous molecule by matrix met-
alloproteinases within minutes of cell surface expression [9].
Membrane Fas ligand can be cleaved by metalloproteinases to release soluble protein seg-
ments. The soluble and membranous forms of the Fas ligand have different functions in 
apoptosis. Membranous Fas ligand is the primary mediator of apoptosis through forma-
tion of trimers and higher-order structures on the cell surface, while soluble Fas ligand can 
have proapoptotic, antiapoptotic, and neutrophil chemotactic functions, depending on the 
nature of other contextual mediators in the microenvironment. Soluble Fas ligand exists as 
a homotrimer, which is ineffective in co-aggregating Fas receptors. Soluble Fas ligand can 
induce apoptosis following aggregation with fibronectin of extracellular matrix proteins 
to form tetramers and higher-order structures. Besides its role in apoptosis, the soluble 
Fas ligand is a potent inflammatory agent; it induces B cell proliferation and IgE synthesis 
in conjunction with IL-4, and soluble B cell activating factor (BAFF) co-stimulates B cells.
Expression of soluble Fas ligand in several cell types has been shown to induce an effusive 
neutrophil-mediated inflammatory response, as documented in vivo by either tissue trans-
plant infiltration or neutrophil extravasation to the peritoneal cavity [18].
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Soluble Fas ligand-binding cells express Fas receptors and lead to apoptosis whereas there 
are some cells that have a default death pathway that can be blocked by a survival factor 
such as a hormone or growth factor [19].
The binding of the Fas ligand to the Fas receptor results in the binding of the adapter pro-
tein Fas-associated death domain (FADD). FADD then associates with procaspase-8 via 
dimerization of the death effector domain forming a death-inducing signaling complex 
(DISC). Once caspase-8 is activated, the execution phase of apoptosis is triggered. Cas-
pases are widely expressed in an inactive proenzyme form in most cells and once activated 
can often activate other procaspases, allowing initiation of a protease cascade. One caspase 
activates other caspases and causes the apoptotic signaling pathway to be activated. Cas-
pases have proteolytic activity and are able to cleave proteins at aspartic acid residues. 
Once caspases are initially activated, it leads an irreversible commitment towards cell 
death. There are 10 major caspases that have been identified and categorized into initiators 
(caspase-2,-8,-9,-10), effectors or executioners (caspase-3,-6,-7), and inflammatory caspases 
(caspase-1,-4,-5) [20].
There are morphological changes that occur during apoptosis. At the early process of ap-
optosis, cell shrinkage and pyknosis occur. At the cell shrinkage stage, the cells are smaller 
in size, the cytoplasm is dense, and the organelles are more tightly packed. Pyknosis is 
the result of chromatin condensation. Furthermore, plasma membrane blebbing occurs 
followed by karyorrhexis and separation of cell fragments into apoptotic bodies. The orga-
nelle integrity is still maintained and all of this is enclosed within an intact plasma mem-
brane. Then, apoptotic bodies are subsequently phagocytosed by macrophages degraded 
within phagolysosomes. There is essentially no inflammatory reaction associated with the 
process of apoptosis [21].
The recent studies show that soluble Fas ligand also induces cellular activation signals. 
Soluble Fas ligand induced monocyte responses to secrete pro-inflammatory cytokines 
and chemotactic factors [22, 23]. Soluble Fas ligand-induced monocyte cytokine responses 
were associated with rapid expression of pro-inflammatory cytokine genes, suggesting at 
least partial regulation at the transcriptional level and involving nuclear factor-kappa beta 
(NF-kB) activation. There are important maturation-dependent differences in the soluble 
Fas ligand that depend on the signaling pathway whether inducing apoptosis or the silent 
disappearance of inflammatory cells. Soluble Fas ligand may serve to activate circulating 
monocytes and recruited macrophages to produce pro-inflammatory mediators that can ini-
tiate acute inflammation. This is may play an important role in the regulation of innate im-
mune responses and may contribute to the pathogenesis of a variety of clinically important 
inflammatory diseases [24].
2.3. Role of soluble Fas ligand in pathogenesis in dengue
Soluble Fas ligand can induce apoptosis and inflammatory responses. Recently the study has 
suggested that excessive inflammation and apoptosis contribute to the pathogenesis of severe 
dengue disease. Although elevated-level cytokines occur in DF patients, the higher level was 
found in severe dengue disease (DHF/DSS) [25]. The evidence has suggested that there is 
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significantly an increase in the number of human tissues that undergo apoptosis in dengue 
disease [26]. Apoptosis in white blood cells, brain cells, intestine, and pulmonary endothelial 
cells form microvasculature in DENV cases. The apoptosis of microvascular endothelial cells 
may be associated with plasma leakage and hemorrhage during DHF/DSS [27].
The interaction between DENV and humans leads to the activation of transcription fac-
tors, cytokines, and enzymatic factors. These interactions may induce not only inflamma-
tory responses but also apoptotic responses that influence the severity and progression of 
the disease. The human monocytes infected in vitro by DENV have upregulated Fas expres-
sion concomitant with the viral peak, indicating that DENV apoptosis is induced by extrinsic 
apoptotic pathway [13].
The dengue patients during acute infection found that TNF-α is the first cytokine detected 
in patients in the peripheral blood mononuclear cell (PBMC) cultures [28]. These findings 
showed that TNF-α and its family members are important apoptosis mediators during DENV 
infection. Among the TNF-α family, the Fas ligand is related to the pathogenesis of dengue 
infection [29–31]. The apoptotic event is an important event in life and is involved in patho-
genesis of dengue infection, and these events occur in response to the variety of signals and 
stimuli, both internal and external. Mitochondria play a central role in mediating intrinsic 
apoptotic signals. Changes in the external membrane mitochondria lead to the production 
of reactive oxygen species related to initial apoptotic events. The extrinsic signal that usually 
induced apoptosis is by a death receptor such as Fas receptor binding to Fas ligand. After sig-
naling, an enzymatic cascade leads to the activation of a series of cysteinyl aspartate proteases 
known as caspases and then to cell degradation [29]. DENV can induce apoptosis in DENV-
infected cells and disseminate its viral progenies to the neighbor cells. The induction of apop-
tosis may be an attempt by the host immune system to limit the extent of the infection [13].
Apoptotic signaling may first be triggered by the interaction of the DENV envelope protein 
with the endosomal membrane during the fusion process while newly synthesized viral pro-
teins may enhance apoptosis. There was indicate the involvement of NF-kB in mediating 
apoptosis. DENV triggers an apoptotic pathway through phospholipase A2 (PLA2) activation 
to superoxide anion generation and subsequently to NF-kB activation.
This apoptotic effect can be either directly derived from the action of arachidonic acid (AA) 
and superoxide anion on the mitochondria or indirectly derived from the products of apopto-
sis-related genes activated by NF-kB [32].
The recent study showed that soluble Fas ligand can be used as a potential marker of sever-
ity of dengue infection because the study showed that there was a significant increase in the 
soluble Fas ligand level in DHF patients compared to DF patients [33].
3. Conclusions
Soluble Fas ligand contributes to the pathogenesis of the severe dengue disease. The interac-
tions between DENV and humans induce not only inflammatory responses but also apoptotic 
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responses that influence the severity and progression of the disease. Soluble Fas ligand can 
induce apoptosis and is a potent inflammatory agent.
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